ACRI CAPITAL ACQUISITION COR (ACAC) Stock Fundamental Analysis

NASDAQ:ACAC • US00501A1016

11.2 USD
-1.75 (-13.51%)
At close: Sep 26, 2024
11.3 USD
+0.1 (+0.89%)
After Hours: 9/26/2024, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ACAC. ACAC was compared to 0 industry peers in the Unkown industry. ACAC may be in some trouble as it scores bad on both profitability and health. ACAC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ACAC had positive earnings in the past year.
  • ACAC had a negative operating cash flow in the past year.
ACAC Yearly Net Income VS EBIT VS OCF VS FCFACAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 500K -500K

1.2 Ratios

Industry RankSector Rank
ROA 1.35%
ROE 1.85%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACAC Yearly ROA, ROE, ROICACAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 1 -1 2

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACAC Yearly Profit, Operating, Gross MarginsACAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • ACAC has less shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ACAC is higher compared to a year ago.
ACAC Yearly Shares OutstandingACAC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2M 4M 6M 8M 10M
ACAC Yearly Total Debt VS Total AssetsACAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 20M 40M 60M 80M

2.2 Solvency

  • ACAC has an Altman-Z score of 3.88. This indicates that ACAC is financially healthy and has little risk of bankruptcy at the moment.
  • A Debt/Equity ratio of 0.16 indicates that ACAC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 3.88
ROIC/WACCN/A
WACCN/A
ACAC Yearly LT Debt VS Equity VS FCFACAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M 40M 60M 80M

2.3 Liquidity

  • ACAC has a Current Ratio of 0.02. This is a bad value and indicates that ACAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • A Quick Ratio of 0.02 indicates that ACAC may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
ACAC Yearly Current Assets VS Current LiabilitesACAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • ACAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -50.47%.
EPS 1Y (TTM)-50.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-367.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACAC Yearly Revenue VS EstimatesACAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 100M 200M 300M 400M
ACAC Yearly EPS VS EstimatesACAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 0.1 0.2 0.3

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 280.00, which means the current valuation is very expensive for ACAC.
  • Compared to an average S&P500 Price/Earnings ratio of 27.16, ACAC is valued quite expensively.
Industry RankSector Rank
PE 280
Fwd PE N/A
ACAC Price Earnings VS Forward Price EarningsACAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACAC Per share dataACAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ACAC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

ACRI CAPITAL ACQUISITION COR

NASDAQ:ACAC (9/26/2024, 8:00:00 PM)

After market: 11.3 +0.1 (+0.89%)

11.2

-1.75 (-13.51%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners18.73%
Inst Owner Change-85.75%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap44.46M
Revenue(TTM)N/A
Net Income(TTM)286.25K
Analysts100
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 280
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.87
P/tB 2.87
EV/EBITDA N/A
EPS(TTM)0.04
EY0.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0
BVpS3.91
TBVpS3.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.35%
ROE 1.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 3.88
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-367.8%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.86%
OCF growth 3YN/A
OCF growth 5YN/A

ACRI CAPITAL ACQUISITION COR / ACAC FAQ

What is the fundamental rating for ACAC stock?

ChartMill assigns a fundamental rating of 1 / 10 to ACAC.


Can you provide the valuation status for ACRI CAPITAL ACQUISITION COR?

ChartMill assigns a valuation rating of 0 / 10 to ACRI CAPITAL ACQUISITION COR (ACAC). This can be considered as Overvalued.


What is the profitability of ACAC stock?

ACRI CAPITAL ACQUISITION COR (ACAC) has a profitability rating of 0 / 10.